WebbOperating Status Active. Last Funding Type Post-IPO Equity. Legal Name Sangamo Therapeutics, Inc. Stock Symbol NASDAQ:SGMO. Company Type For Profit. Contact Email [email protected]. Phone Number 5102368951. Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic … WebbDescription. Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, …
Sangamo poised for CAR-Treg race Nature Biotechnology
Webb13 apr. 2024 · 5 equities research analysts have issued 12-month price targets for Sangamo Therapeutics' shares. Their SGMO share price forecasts range from $5.00 to $16.00. On average, they anticipate the company's stock price to reach $12.80 in the next year. This suggests a possible upside of 759.1% from the stock's current price. do gildan shirts bleach
Sangamo Therapeutics, Inc.: Sangamo Therapeutics to Present
WebbSangamo Therapeutics, Inc. 4 years 2 months Vice President, Neuroscience Sangamo Therapeutics, Inc. Apr 2024 - Present 3 years 1 … Webb17 mars 2024 · Sangamo Therapeutics Inc.’s market cap currently stands at around $365.21 million, with investors looking forward to this quarter’s earnings report slated for May 03, 2024 – May 08, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.36, which has seen fiscal year 2024 EPS growth forecast to increase to -$1.3 and … WebbAnswerThePublic listens into autocomplete data from search engines like Google then quickly cranks out every useful phrase and question people are asking around sangamo therapeutics on 02 Feb.. It’s a goldmine of consumer insight you can use to create fresh, ultra-useful content, products and services. do g.i loans permit easements on the property